Home Casteddu.com FAQ My Amedeo About Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Breast Cancer

 

Free Subscription


12.05.2009

1 Am J Pathol
2 Ann Surg Oncol
6 Anticancer Res
2 BMC Cancer
1 Br J Cancer
3 Breast Cancer Res
3 Breast Cancer Res Treat
2 Cancer Lett
1 Cancer Res
5 Clin Cancer Res
3 Int J Cancer
1 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
3 J Surg Oncol
3 Lancet Oncol
5 Oncogene
2 Oncology
4 Oncology (Williston Park)
2 Proc Natl Acad Sci U S A
1 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. SLOAN EK , Ciocca DR, Pouliot N, Natoli A, et al
    Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer.
    Am J Pathol. 2009.
    PubMed     Related articles    Abstract available


    Ann Surg Oncol

  2. GIMBERGUES P , Abrial C, Durando X, Le Bouedec G, et al
    Clinicopathological Factors and Nomograms Predicting Nonsentinel Lymph Node Metastases After Neoadjuvant Chemotherapy in Breast Cancer Patients.
    Ann Surg Oncol. 2009.
    PubMed     Related articles    Abstract available

  3. VADAPARAMPIL ST , Quinn GP, Miree CA, Brzosowicz J, et al
    Recall of and Reactions to a Surgeon Referral Letter for BRCA Genetic Counseling Among High-Risk Breast Cancer Patients.
    Ann Surg Oncol. 2009.
    PubMed     Related articles    Abstract available


    Anticancer Res

  4. OKARVI SM , Jammaz IA
    Design, Synthesis, Radiolabeling and In Vitro and In Vivo Characterization of Tumor-antigen- and Antibody-derived Peptides for the Detection of Breast Cancer.
    Anticancer Res. 2009;29:1399-409.
    PubMed     Related articles    Abstract available

  5. SEIFEDDINE R , Fulchignoni-Lataud MC, Massaad-Massade L
    Down-regulation of C/EBP{alpha} in Breast Cancer Cells by Hypoxia-Estrogen Combination is Mainly Due to Hypoxia.
    Anticancer Res. 2009;29:1227-31.
    PubMed     Related articles    Abstract available

  6. SHEEN-CHEN SM , Zhang H, Huang CC, Tang RP, et al
    Insulin-like Growth Factor-binding Protein-3 in Breast Cancer: Analysis with Tissue Microarray.
    Anticancer Res. 2009;29:1131-5.
    PubMed     Related articles    Abstract available

  7. KULENDRAN M , Salhab M, Mokbel K
    Oestrogen-synthesising enzymes and breast cancer.
    Anticancer Res. 2009;29:1095-109.
    PubMed     Related articles    Abstract available

  8. KATAYAMA K , Shibata K, Mitsuhashi J, Noguchi K, et al
    Pharmacological Interplay between Breast Cancer Resistance Protein and Gefitinib in Epidermal Growth Factor Receptor Signaling.
    Anticancer Res. 2009;29:1059-65.
    PubMed     Related articles    Abstract available

  9. KAMEDA C , Tanaka H, Yamasaki A, Nakamura M, et al
    The Hedgehog Pathway Is a Possible Therapeutic Target for Patients with Estrogen Receptor-negative Breast Cancer.
    Anticancer Res. 2009;29:871-9.
    PubMed     Related articles    Abstract available


    BMC Cancer

  10. DONG X , Liu A, Zer C, Feng J, et al
    siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells.
    BMC Cancer. 2009;9:133.
    PubMed     Related articles    Abstract available

  11. MENG Y , Gu C, Wu Z, Zhao Y, et al
    Id2 promotes the invasive growth of MCF-7 and SKOV-3 cells by a novel mechanism independent of dimerization to basic helix-loop-helix factors.
    BMC Cancer. 2009;9:75.
    PubMed     Related articles    Abstract available


    Br J Cancer

  12. LAGIOU P , Hsieh CC, Lipworth L, Samoli E, et al
    Insulin-like growth factor levels in cord blood, birth weight and breast cancer risk.
    Br J Cancer. 2009.
    PubMed     Related articles    Abstract available


    Breast Cancer Res

  13. KALRA J , Warburton C, Fang K, Edwards L, et al
    QLT0267, a small molecule inhibitor targeting Integrin-Linked Kinase (ILK), and Docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment out
    Breast Cancer Res. 2009;11:R25.
    PubMed     Related articles    Abstract available

  14. HANCOX RA , Allen MD, Holliday DL, Edwards DR, et al
    Tumor-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms.
    Breast Cancer Res. 2009;11:R24.
    PubMed     Related articles    Abstract available

  15. JACQUEMIER J , Charafe-Jauffret E, Monville F, Esterni B, et al
    Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly pronostic in luminal breast cancer.
    Breast Cancer Res. 2009;11:R23.
    PubMed     Related articles    Abstract available


    Breast Cancer Res Treat

  16. LAHUSEN T , Henke RT, Kagan BL, Wellstein A, et al
    The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.
    Breast Cancer Res Treat. 2009.
    PubMed     Related articles    Abstract available

  17. FESSLER SP , Wotkowicz MT, Mahanta SK, Bamdad C, et al
    MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.
    Breast Cancer Res Treat. 2009.
    PubMed     Related articles    Abstract available

  18. BRINKMAN A , de Jong D, Tuinman S, Azaouagh N, et al
    The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
    Breast Cancer Res Treat. 2009.
    PubMed     Related articles    Abstract available


    Cancer Lett

  19. ZHANG Y , Qian RQ, Li PP
    Shikonin, an ingredient of Lithospermum erythrorhizon, down-regulates the expression of steroid sulfatase genes in breast cancer cells.
    Cancer Lett. 2009.
    PubMed     Related articles    Abstract available

  20. VALDIVIA-SILVA JE , Franco-Barraza J, Silva AL, Pont GD, et al
    Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis.
    Cancer Lett. 2009.
    PubMed     Related articles    Abstract available


    Cancer Res

  21. MILANI M , Rzymski T, Mellor HR, Pike L, et al
    The Role of ATF4 Stabilization and Autophagy in Resistance of Breast Cancer Cells Treated with Bortezomib.
    Cancer Res. 2009.
    PubMed     Related articles    Abstract available


    Clin Cancer Res

  22. ROJO F , Gonzalez-Navarrete I, Bragado R, Dalmases A, et al
    Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin.
    Clin Cancer Res. 2009.
    PubMed     Related articles    Abstract available

  23. BAAR J , Silverman P, Lyons J, Fu P, et al
    A Vasculature-Targeting Regimen of Preoperative Docetaxel with or without Bevacizumab for Locally Advanced Breast Cancer: Impact on Angiogenic Biomarkers.
    Clin Cancer Res. 2009.
    PubMed     Related articles    Abstract available

  24. LITZENBURGER BC , Kim HJ, Kuiatse I, Carboni JM, et al
    BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.
    Clin Cancer Res. 2009;15:226-37.
    PubMed     Related articles    Abstract available

  25. DENG T , Liu JC, Pritchard KI, Eisen A, et al
    Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
    Clin Cancer Res. 2009;15:119-30.
    PubMed     Related articles    Abstract available

  26. BITLER BG , Menzl I, Huerta CL, Sands B, et al
    Intracellular MUC1 peptides inhibit cancer progression.
    Clin Cancer Res. 2009;15:100-9.
    PubMed     Related articles    Abstract available


    Int J Cancer

  27. WRIGHT TG , Singh VK, Li JJ, Foley JH, et al
    Increased production and secretion of HGF alpha-chain and an antagonistic HGF fragment in a human breast cancer progression model.
    Int J Cancer. 2009.
    PubMed     Related articles    Abstract available

  28. SANGRAJRANG S , Sato Y, Sakamoto H, Ohnami S, et al
    Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women.
    Int J Cancer. 2009.
    PubMed     Related articles    Abstract available

  29. TERRASI M , Fiorio E, Mercanti A, Koda M, et al
    Functional analysis of the -2548G/A leptin gene polymorphism in breast cancer cells.
    Int J Cancer. 2009.
    PubMed     Related articles    Abstract available


    Int J Radiat Oncol Biol Phys

  30. STROOM J , Schlief A, Alderliesten T, Peterse H, et al
    Using Histopathology Breast Cancer Data to Reduce Clinical Target Volume Margins at Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2009.
    PubMed     Related articles    Abstract available


    J Clin Oncol

  31. SCHONBERG MA , Silliman RA, Marcantonio ER
    Weighing the benefits and burdens of mammography screening among women age 80 years or older.
    J Clin Oncol. 2009;27:1774-80.
    PubMed     Related articles    Abstract available

  32. LU H
    FOXP3 expression and prognosis: role of both the tumor and T cells.
    J Clin Oncol. 2009;27:1735-6.
    PubMed     Related articles   


    J Surg Oncol

  33. POCKAJ BA , Degnim AC, Boughey JC, Gray RJ, et al
    Quality of life after breast cancer surgery: What have we learned and where should we go next?
    J Surg Oncol. 2009;99:447-455.
    PubMed     Related articles    Abstract available

  34. EL-TAMER M
    Surgical options as quality of care indicators in breast cancer.
    J Surg Oncol. 2009;99:393-394.
    PubMed     Related articles   

  35. BLEICHER RJ , Kloth DD, Robinson D, Axelrod P, et al
    Inflammatory cutaneous adverse effects of methylene blue dye injection for lymphatic mapping/sentinel lymphadenectomy.
    J Surg Oncol. 2009;99:356-60.
    PubMed     Related articles    Abstract available


    Lancet Oncol

  36. LABRIE F , Martel C
    Concurrent hormone and radiation therapy in patients with breast cancer: how does chemotherapy affect treatment?
    Lancet Oncol. 2009;10:444-5.
    PubMed     Related articles   

  37. YU KD , Shao ZM
    Concurrent hormone and radiation therapy in patients with breast cancer: how does chemotherapy affect treatment?
    Lancet Oncol. 2009;10:442-4.
    PubMed     Related articles   

  38. BOYD N , Martin L, Chavez S, Gunasekara A, et al
    Breast-tissue composition and other risk factors for breast cancer in young women: a cross-sectional study.
    Lancet Oncol. 2009.
    PubMed     Related articles    Abstract available


    Oncogene

  39. WU D , Asiedu M, Wei Q
    Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
    Oncogene. 2009.
    PubMed     Related articles    Abstract available

  40. KATO M , Paranjape T, Ullrich R, Nallur S, et al
    The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells.
    Oncogene. 2009.
    PubMed     Related articles    Abstract available

  41. SMITH JR , Clarke PA, de Billy E, Workman P, et al
    Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.
    Oncogene. 2009;28:157-69.
    PubMed     Related articles    Abstract available

  42. MOLLER A , House CM, Wong CS, Scanlon DB, et al
    Inhibition of Siah ubiquitin ligase function.
    Oncogene. 2009;28:289-96.
    PubMed     Related articles    Abstract available

  43. CRANE CA , Panner A, Murray JC, Wilson SP, et al
    PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.
    Oncogene. 2008.
    PubMed     Related articles    Abstract available


    Oncology

  44. AMADORI A , Rossi E, Zamarchi R, Carli P, et al
    Circulating and Disseminated Tumor Cells in the Clinical Management of Breast Cancer Patients: Unanswered Questions.
    Oncology. 2009;76:375-386.
    PubMed     Related articles    Abstract available

  45. LE BRUN-LY V , Martin J, Venat-Bouvet L, Darodes N, et al
    Cardiac toxicity with capecitabine, vinorelbine and trastuzumab therapy: case report and review of fluoropyrimidine-related cardiotoxicity.
    Oncology. 2009;76:322-5.
    PubMed     Related articles    Abstract available


    Oncology (Williston Park)

  46. CRIPPA F , Bombardieri E
    Nuclear medicine imaging in breast cancer: current strategies and future directions.
    Oncology (Williston Park). 2009;23:269-70.
    PubMed     Related articles   

  47. BENARD F
    The challenges of improving breast cancer outcome with diagnostic imaging techniques.
    Oncology (Williston Park). 2009;23:264.
    PubMed     Related articles   

  48. ALMUBARAK M , Osman S, Marano G, Abraham J, et al
    Role of positron-emission tomography scan in the diagnosis and management of breast cancer.
    Oncology (Williston Park). 2009;23:255-61.
    PubMed     Related articles    Abstract available

  49. HERSHMAN DL , Shao T
    Anthracycline cardiotoxicity after breast cancer treatment.
    Oncology (Williston Park). 2009;23:227-34.
    PubMed     Related articles    Abstract available


    Proc Natl Acad Sci U S A

  50. CALDAS-LOPES E , Cerchietti L, Ahn JH, Clement CC, et al
    Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models.
    Proc Natl Acad Sci U S A. 2009.
    PubMed     Related articles    Abstract available

  51. PITRODA SP , Khodarev NN, Beckett MA, Kufe DW, et al
    MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment.
    Proc Natl Acad Sci U S A. 2009;106:5837-41.
    PubMed     Related articles    Abstract available


    Radiology

  52. SALA M , Comas M, Macia F, Martinez J, et al
    Implementation of Digital Mammography in a Population-based Breast Cancer Screening Program: Effect of Screening Round on Recall Rate and Cancer Detection.
    Radiology. 2009.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: